Staying Focused On Long Term Priorities 
   JACOBSON PHARMA CORPORATION LIMITED 
   Incorporated under the laws of the Cayman Islands with limited liability
        :
   Stock Code   2633
                                          Annual Report 2020
                                             CONTENTS
                                             1                                     71
                                             Corporate Information                 Independent Auditor’s Report
                                             2                                     76
                                             Financial Highlights                  Consolidated Statement of 
                                                                                   Profit or Loss and Other 
                                             4                                     Comprehensive Income
                                             Letter to Shareholders                78
                                             6                                     Consolidated Statement of 
                                             Corporate Vision and Mission          Financial Position
                                             7                                     79
                                             Corporate Profile                     Consolidated Statement of 
                                             8                                     Changes in Equity
                                             Management                            80
                                             Discussion and Analysis               Consolidated 
                                             26                                    Cash Flow Statement
                                             Corporate Governance Report           81
                                                                                   Notes to the 
                                             38                                    Financial Statements
                                             Environmental, Social and             149
                                             Governance Report
                                             58                                    Five-year Financial Summary
                                             Report of the Directors               150
                                                                                   Glossary
                                                                                   CORPORATE INFORMATION
                                                                                   BOARD OF DIRECTORS                                                 HONG KONG HEADQUARTERS AND 
                                                                                   Executive Directors                                                PRINCIPAL PLACE OF BUSINESS
                                                                                   Mr. Sum Kwong Yip, Derek                                           Unit 2313-18, 23/F
                                                                                   (Chairman and Chief Executive Officer)                             Tower 1, Millennium City 1
                                                                                   Mr. Yim Chun Leung                                                 388 Kwun Tong Road
                                                                                   Ms. Pun Yue Wai                                                    Kwun Tong, Kowloon
                                                                                                                                                      Hong Kong
                                                                                   Non-executive Director                                             PRINCIPAL SHARE REGISTRAR 
                                                                                   Professor Lam Sing Kwong, Simon                                    AND TRANSFER OFFICE
                                                                                   Independent Non-executive Directors                                Conyers Trust Company (Cayman) Limited 
                                                                                   Dr. Lam Kwing Tong, Alan                                           Cricket Square 
                                                                                   Mr. Young Chun Man, Kenneth                                        Hutchins Drive 
                                                                                   Professor Wong Chi Kei, Ian                                        PO Box 2681 
                                                                                                                                                      Grand Cayman KY1-1111 
                                                                                   AUDIT COMMITTEE                                                    Cayman Islands
                                                                                   Mr. Young Chun Man, Kenneth (Chairman)                             HONG KONG BRANCH SHARE 
                                                                                   Dr. Lam Kwing Tong, Alan                                           REGISTRAR 
                                                                                   Professor Wong Chi Kei, Ian                                        Tricor Investor Services Limited 
                                                                                   REMUNERATION COMMITTEE                                             Level 54, Hopewell Centre 
                                                                                   Dr. Lam Kwing Tong, Alan (Chairman)                                183 Queen’s Road East 
                                                                                   Mr. Young Chun Man, Kenneth                                        Hong Kong 
                                                                                   Ms. Pun Yue Wai                                                    AUDITOR 
                                                                                   NOMINATION COMMITTEE                                               KPMG
                                                                                                                                                      Certified Public Accountant
                                                                                   Professor Wong Chi Kei, Ian (Chairman)                             Public Interest Entity Auditor registered 
                                                                                   Dr. Lam Kwing Tong, Alan                                           in accordance with the Financial 
                                                                                   Mr. Young Chun Man, Kenneth                                        Reporting Council Ordinance
                                                                                   Mr. Yim Chun Leung 
                                                                                                                                                      PRINCIPAL BANKERS 
                                                                                   AUTHORISED REPRESENTATIVES                                         (In alphabetical order)
                                                                                   Mr. Yim Chun Leung                                                 China Construction Bank (Asia) 
                                                                                   Ms. Pun Yue Wai                                                    Corporation Ltd.
                                                                                                                                                      Standard Chartered Bank (Hong Kong) 
                                                                                   COMPANY SECRETARY                                                  Limited
                                                                                   Mr. Yim Chun Leung                                                 The Hongkong and Shanghai Banking 
                                                                                                                                                      Corporation Limited 
                                                                                   REGISTERED OFFICE                                                  PUBLIC RELATIONS CONSULTANT 
                                                                                   Cricket Square                                                     Strategic Public Relations Group 
                                                                                   Hutchins Drive 
                                                                                   PO Box 2681                                                        INVESTOR RELATIONS
                                                                                   Grand Cayman KY1-1111                                              Email: jacobsonpharma@sprg.com.hk
                                                                                   Cayman Islands
                                                                                                                                                      STOCK CODE 
                                                                                                                                                      2633 
                                                                                                                                                      COMPANY WEBSITE 
                                                                                                                                                      www.jacobsonpharma.com
                           JACOBSON PHARMA CORPORATION LIMITED
              002    
              FINANCIAL HIGHLIGHTS
              Revenue                                                                     Adjusted Profit Attributable
              (HK$’000)                                                                   to Shareholders
              1,800,000                                                                   (HK$’000)
              1,600,000                                                                     300,000  
              1,400,000                                                                     250,000  
              1,200,000                                                                     200,000  
              1,000,000  
                800,000                                                                     150,000  
                600,000                                                                     100,000  
                400,000  
                200,000                                                                      50,000  
                     0                                                                            0  
                         FY2016 FY2017 FY2018 FY2019 FY2020                                           FY2016 FY2017 FY2018 FY2019 FY2020
                                                 (Restated)(1)                                                               (Restated)(1)
                 Generic Drugs     Proprietary Medicines    Wholesale and Retail                          Profit Attributable to Shareholders
                                                                                                          One-Off Listing Expenses
              Adjusted EBITDA                                                             Net Assets
              (HK$’000)                                                                   (HK$’000)
                500,000                                                                    3,000,000  
                450,000  
                400,000                                                                    2,500,000  
                350,000                                                                    2,000,000  
                300,000  
                250,000                                                                    1,500,000  
                200,000  
                150,000                                                                    1,000,000  
                100,000                                                                     500,000  
                 50,000  
                     0                                                                            0  
                         FY2016 FY2017 FY2018 FY2019 FY2020                                           FY2016 FY2017 FY2018 FY2019 FY2020
                                                 (Restated)(1)
                  Generic Drugs      Proprietary Medicines    Wholesale and Retail
              Net Debts                                                                   Net Gearing Ratio
              (HK$’000)
              1,200,000                                                                   0.5  
              1,000,000                                                                   0.4  
                800,000                                                                   0.3  
                600,000  
                                                                                          0.2  
                400,000  
                200,000                                                                   0.1  
                      0                                                                   0.0  
                         FY2016 FY2017 FY2018 FY2019 FY2020                                    FY2016 FY2017 FY2018 FY2019 FY2020